Generic Pharmaceuticals Businesses for Sale

The unit is situated in an Industrial Park of Nalgonda, Telangana. - Built on owned land, 95% of the setup is done but the plant is not operational yet. - The unit was established as a pharmaceutical formulations manufacturing unit for production of tablets, liquids and capsules. - Since the plant is currently only 95% complete, the installed maximum production capacity cannot be reliably stated at this stage. The final capacity will depend on the completion of installation, commissioning, and equipment validation. - The facility is not USFDA approved, however, it already possesses Pollution Control certificate, permission from Commissioner of Industries, and Factories Department. We also have a Certificate of Incorporation and Udyam Registration Certificate.

We’re a new, WHO GMP-certified pharmaceutical formulations manufacturing company located near Ahmedabad. - Our facility specializes in creating a variety of products, including oral liquids, tablets, capsules, and external preparations like ointments and gels. - We have secured approvals for various formulations, including some high-value specialty products that stand out in the market. - Our plant is built to meet top-tier standards set by the EU and USFDA, ensuring high-quality, export-ready products. - With high-volume production capabilities, we’re geared up to meet significant demand as we grow. - We currently have no clients or revenue, so there’s great potential for investors to come in and help scale our operations. - Our team of 40 dedicated employees is equipped to drive our mission of delivering excellent pharmaceuticals. - Being brand new, we offer a unique opportunity for investors to tap into a fresh market in the booming generic pharmaceuticals sector.

Located near Delhi, the company is a profitable chemical and API pharma business with a turnover exceeding INR 140 Crore. - The facility has a production capacity of 200 tonnes per annum, enabling efficient fulfillment of client demand. - The plant and machinery are maintained in excellent condition, supporting high-quality production processes. - The company is fully compliant with GMP, GST, MCA, and FSSAI regulations, ensuring adherence to industry standards. Not USFDA approved. - The core business focuses on Indian-based API production, supplying to select pharmaceutical clients pan India. (Detailed client list will be shared will be shared with potential buyers) - The workforce includes 100 permanent employees, with additional temporary and contract staff hired for production and logistics as required.

Located near Delhi, the company is a profitable chemical and API pharma business with a turnover exceeding INR 140 Crore. - The facility has a production capacity of 200 tonnes per annum, enabling efficient fulfillment of client demand. - The plant and machinery are maintained in excellent condition, supporting high-quality production processes. - The company is fully compliant with GMP, GST, MCA, and FSSAI regulations, ensuring adherence to industry standards. Not USFDA approved. - The core business focuses on Indian-based API production, supplying to select pharmaceutical clients pan India. (Detailed client list will be shared will be shared with potential buyers) - The workforce includes 100 permanent employees, with additional temporary and contract staff hired for production and logistics as required.

• Owned a pharmaceutical formulation manufacturing unit specializing in antibiotics and beta-lactam products. • Manufactures tablets, capsules, and dry syrups under regulated pharmaceutical standards. • Product portfolio includes approximately 40 SKUs across therapeutic categories. • Produces formulations under its own brand through an established distributor network. • Also undertakes third-party/job work manufacturing for external pharma companies. • Installed tablet manufacturing capacity of around 1.5 crore tablets per month per shift. • Capsule manufacturing capacity of approximately 50 lakh capsules per month per shift. • Dry syrup production capacity of about 40,000–50,000 bottles per month per shift. • Currently operating at around 5% capacity utilization, leaving substantial headroom for scale-up. • Business activity has reduced over the past two years due to promoter health and age-related constraints. • Sales decline attributed to operational slowdown rather than market or regulatory issues. • Holds valid drug manufacturing license for regulated formulations. • Registered under GST and MSME, ensuring statutory and compliance readiness. Does not have USFDA approval. • Suitable for revival through professional management, marketing tie-ups, or strategic investment.

• Established generic pharmaceutical manufacturing unit located in Hyderabad, operational for over 5 years. • Built-up area of 60,000 sq. ft. across 4 floors, each dedicated to specific product lines (tablets, capsules, syrups and powders). • Licensed for manufacturing 300+ medicines and holds GMP certification. • Expansion potential to INR 12–15 crore annually with sufficient working capital infusion. • In-house distribution house established, supported by third-party manufacturing orders. • Current output: 10,000 tablets/day and 500 liters syrup/day with 1 batch/day. • Installed capacity allows up to 3 batches/day for significantly higher production. • Open to outright sale, partial stake (10–80%), or long lease arrangements.

State-of-the-art pharmaceutical R&D facility located in Verna Industrial Estate, South Goa, a prime pharma corridor near ports and airports, and home to top pharma companies like Pfizer, Cipla, Sanofi, Abbott, and Colorcon. In proximity to upcoming dedicated IT Park. - The business can operate on a B2B collaboration model, focusing on R&D execution rather than direct sales of medicine. - Fully equipped, ready-to-operate 3-floor R&D building with dedicated areas for administration, formulation development, and analytical development; upcoming 4-floor pilot manufacturing building beside R&D. - FDA-approved plan from the State of Goa, enabling immediate start of operations with necessary licenses and compliance for both domestic and international markets. - It is a land of 1,800 m² space with 24/7 CCTV, controlled access, a robust electric supply, water purification systems, ETP-certified waste management, and fire safety compliance. The promoter has permission to sublease the property. - Formulation lab fitted with clean rooms, HVAC & AHU systems, HEPA filters, and equipment including high-shear granulators, fluid bed dryers, nano-milling systems, spray drying tech, multi-layer tablet press, and encapsulation machines. - Analytical lab equipped with advanced instruments such as Malvern Mastersizer, UHPLC, FTIR, DSC, dissolution apparatus, and gas chromatography systems; stability chambers for long-term studies. - The administration area includes open workspaces, conference and meeting rooms, reception, and executive cabins for quality, regulatory, and operational teams. - Additional features: 800 KVA transformer, 380 KVA diesel generator (CPCB-II certified), 160 KVA UPS backup, rainwater drainage, ample parking, and logistics-friendly loading bays. - Offered on a turnkey sale asset basis with all machinery and infrastructure included from day 1, ensuring cost-effective setup and rapid operational launch.

Located in Kolkata, this pharmaceutical company specializes in manufacturing a range of pharmaceutical products. - Primary products include liquid syrups, suspensions, tablets, capsules, eye drops, and oral solutions. - Supplies its products primarily to distributors and pharmacies in West Bengal and other states such as Bihar, Odisha, Assam, Jharkhand, and North-East India. - Production capabilities include 5,000-20,000 units of liquid syrups and suspensions per month, 100,000-300,000 tablets monthly, and 2,000-5,000 eye drops and oral solutions each month. - Verified seller on TradeIndia, renowned for providing high-quality pharmaceutical syrups and tablets. - The company is not USFDA approved but has a valid drug license under the Department of Health and Family Welfare, Government of West Bengal.

The company is a WHO GMP standard pharmaceutical firm located in Hinganghat, referred to as the center of India, positioning it strategically for robust distribution. - We specialize in manufacturing high-quality generic drugs, focusing specifically on tablet and capsule forms to cater to a wide range of healthcare needs. - With an impressive manufacturing capacity, the company can produce up to 40 lakh tablets per day, ensuring the ability to meet both domestic and international demand efficiently. - As an FDA-approved entity in the countries where they export, the business adheres to stringent quality regulations, enhancing their credibility and reliability on a global scale. - The business predominantly generates revenue through exports, supported by approvals from NAFDAC, Ghana, and Uzbek FDA, indicating strong international market presence. - Operating on a job work model, the company collaborates with over 10 merchant exporters who have registered products, demonstrating robust partnerships in the pharmaceutical export industry. - The promoters bring over 25 years of combined experience, underscoring the business's depth in pharmaceutical industry knowledge and operational prowess. - There are 80 permanent employees, with additional contract or temporary staff hired for manufacturing and logistics based on operational needs and demand.

Located in malanpur near Gwalior, this pharmaceutical business specializes in third-party manufacturing for nutraceutical and ayurvedic medicines. - Manufacturing capabilities include liquid-oral, oils, tablets, capsules, and powder, catering to various healthcare needs. - Led by a promoter with over 30 years of industry experience, including tenure at Cipla and Wockhardt. - The facility has a daily production capacity of 5000 liquid oral bottles, 100,000 tablets, and 30,000 capsules. 3000 powder pack, 3000 oils pack per shift. - Holds a valid nutraceutical, general, drug and ayurvedic license, ensuring compliance with industry regulations. - Operates with a small, skilled team of 8 employees for efficient and cost-effective production.